Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis

Miller, K. D. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J. Clin. 71, 381–406 (2021).Article 
PubMed 

Google Scholar 
Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2015–2019. Neuro Oncol. 24, v1–v95 (2022).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).Article 
CAS 
PubMed 

Google Scholar 
Reardon, D. A. & Wen, P. Y. Glioma in 2014: Unravelling tumour heterogeneity-implications for therapy. Nat. Rev. Clin. Oncol. 12, 69–70 (2015).Article 
CAS 
PubMed 

Google Scholar 
Mansouri, A. et al. MGMT promoter methylation status testing to guide therapy for glioblastoma: Refining the approach based on emerging evidence and current challenges. Neuro Oncol. 21, 167–178 (2019).Article 
CAS 
PubMed 

Google Scholar 
Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997–1003 (2005).Article 
CAS 
PubMed 

Google Scholar 
Riemenschneider, M. J., Hegi, M. E. & Reifenberger, G. MGMT promoter methylation in malignant gliomas. Target Oncol. 5, 161–165 (2010).Article 
PubMed 

Google Scholar 
Wick, W. et al. MGMT testing–the challenges for biomarker-based glioma treatment. Nat. Rev. Neurol. 10, 372–385 (2014).Article 
CAS 
PubMed 

Google Scholar 
Iliadis, G. et al. Volumetric and MGMT parameters in glioblastoma patients: Survival analysis. BMC Cancer 12, 3 (2012).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Ellingson, B. M. et al. Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am. J. Neuroradiol. 34, 533–540 (2013).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Smits, M. & van den Bent, M. J. Imaging correlates of adult glioma genotypes. Radiology 284, 316–331 (2017).Article 
PubMed 

Google Scholar 
Han, Y. et al. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: A region of interest based analysis. BMC Cancer 18, 215 (2018).Article 
PubMed 
PubMed Central 

Google Scholar 
Drabycz, S. et al. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage 49, 1398–1405 (2010).Article 
CAS 
PubMed 

Google Scholar 
Hong, E. K. et al. Comparison of genetic profiles and prognosis of high-grade gliomas using quantitative and qualitative MRI features: A focus on G3 gliomas. Korean J. Radiol. 22, 233–242 (2021).Article 
PubMed 

Google Scholar 
Hong, E. K. et al. Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma. Eur. Radiol. 28, 4350–4361 (2018).Article 
PubMed 

Google Scholar 
Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: Images are more than pictures, they are data. Radiology 278, 563–577 (2016).Article 
PubMed 

Google Scholar 
Lambin, P. et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749–762 (2017).Article 
PubMed 

Google Scholar 
Zhong, S. et al. Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics. J. Neurosurg. https://doi.org/10.3171/2022.10.JNS22801 (2022).Article 
PubMed 

Google Scholar 
van der Voort, S. R. et al. Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Neuro Oncol. 25, 279–289 (2023).Article 
PubMed 

Google Scholar 
Li, G. et al. An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 145, 1151–1161 (2022).Article 
PubMed 
PubMed Central 

Google Scholar 
Li, Z. et al. Combination of pre-treatment dynamic [(18)F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma. Eur. J. Nucl. Med. Mol. Imaging 50, 535–545 (2023).Article 
CAS 
PubMed 

Google Scholar 
Kickingereder, P. et al. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin. Cancer Res. 22, 5765–5771 (2016).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Tian, Q. et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI. J. Magn. Reson. Imaging 48, 1518–1528 (2018).Article 
PubMed 

Google Scholar 
Artzi, M., Bressler, I. & Ben Bashat, D. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis. J. Magn. Reson. Imaging 50, 519–528 (2019).Article 
PubMed 

Google Scholar 
Qian, Z. et al. Machine learning-based analysis of magnetic resonance radiomics for the classification of gliosarcoma and glioblastoma. Front. Oncol. 11, 699789 (2021).Article 
PubMed 
PubMed Central 

Google Scholar 
Pati, S. et al. Federated learning enables big data for rare cancer boundary detection. Nat. Commun. 13, 7346 (2022).Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Sloan, A. E. et al. Radiomics-based identification of peritumoral infiltration in de novo glioblastoma imaging presents targets amenable for potential targeted extended resection: A neurosurgical survey. J. Clin. Oncol. 37, e13573–e13573 (2019).Article 

Google Scholar 
Zhang, J. et al. Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Eur. Radiol. 33, 3332–3342 (2023).Article 
PubMed 

Google Scholar 
Elshafeey, N. et al. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat. Commun. 10, 3170 (2019).Article 
ADS 
PubMed 
PubMed Central 

Google Scholar 
Nicholson, J. G. & Fine, H. A. Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov. 11, 575–590 (2021).Article 
CAS 
PubMed 

Google Scholar 
Li, Z. C. et al. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma. Cancer Med. 7, 5999–6009 (2018).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Eoli, M. et al. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin. Cancer Res. 13, 2606–2613 (2007).Article 
CAS 
PubMed 

Google Scholar 
Kanas, V. G. et al. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Comput. Methods Programs Biomed. 140, 249–257 (2017).Article 
PubMed 

Google Scholar 
Hu, L. S., Hawkins-Daarud, A., Wang, L., Li, J. & Swanson, K. R. Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett. 477, 97–106 (2020).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Kandalgaonkar, P. et al. Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach. Front. Oncol. 12, 879376 (2022).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Li, Z. C. et al. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study. Eur. Radiol. 28, 3640–3650 (2018).Article 
PubMed 

Google Scholar 
Wei, J. et al. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Eur. Radiol. 29, 877–888 (2019).Article 
PubMed 

Google Scholar 
Yogananda, C. G. B. et al. MRI-based deep-learning method for determining glioma MGMT promoter methylation status. AJNR Am. J. Neuroradiol. 42, 845–852 (2021).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Baid, U. et al. The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation and Radiogenomic Classification. https://arxiv.org/abs/2107.02314 (2021).Kim, B. H. et al. Validation of MRI-based models to predict MGMT promoter methylation in gliomas: BraTS 2021 radiogenomics challenge. Cancers (Basel) 14, 4827 (2022).Article 
CAS 
PubMed 

Google Scholar 
Capuozzo, S., Gravina, M., Gatta, G., Marrone, S. & Sansone, C. A multimodal knowledge-based deep learning approach for MGMT promoter methylation identification. J. Imaging 8, 321 (2022).Article 
PubMed 
PubMed Central 

Google Scholar 
Faghani, S., Khosravi, B., Moassefi, M., Conte, G. M. & Erickson, B. J. A comparison of three different deep learning-based models to predict the MGMT promoter methylation status in glioblastoma using brain MRI. J. Digit. Imaging 36, 837–846 (2023).Article 
PubMed 
PubMed Central 

Google Scholar 
Saxena, S. et al. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation. Comput. Biol. Med. 153, 106492 (2023).Article 
CAS 
PubMed 

Google Scholar 
He, J. et al. Multiparametric MR radiomics in brain glioma: Models comparation to predict biomarker status. BMC Med. Imaging 22, 137 (2022).Article 
PubMed 
PubMed Central 

Google Scholar 
Huang, W. Y. et al. Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis. Cancer Sci. 112, 2835–2844 (2021).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Chen, X. et al. Automatic prediction of MGMT status in glioblastoma via deep learning-based MR image analysis. Biomed. Res. Int. 2020, 9258649 (2020).PubMed 
PubMed Central 

Google Scholar 
Tan, Y. et al. Whole-tumor radiomics analysis of DKI and DTI may improve the prediction of genotypes for astrocytomas: A preliminary study. Eur. J. Radiol. 124, 108785 (2020).Article 
PubMed 

Google Scholar 
Moon, W. J., Choi, J. W., Roh, H. G., Lim, S. D. & Koh, Y. C. Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: The CT, diffusion tensor imaging, and perfusion MR imaging. Neuroradiology 54, 555–563 (2012).Article 
PubMed 

Google Scholar 
Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23, 1231–1251 (2021).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar